David Delaney - Oct 17, 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Member of 10% owner group
Signature
/s/ David Delaney
Stock symbol
KTTA
Transactions as of
Oct 17, 2022
Transactions value $
$1,110
Form type
4
Date filed
10/19/2022, 05:29 PM
Previous filing
Aug 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Purchase $1.11K +1K +0.44% $1.11 228K Oct 17, 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased by Elderhill Corporation, of which David Delaney serves as sole director and President.
F2 191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 36,200 shares are held by Elderhill Corporation.